328 related articles for article (PubMed ID: 23283564)
41. [99mTc]cFLFLF for Early Diagnosis and Therapeutic Evaluation in a Rat Model of Acute Osteomyelitis.
Chen J; Cheng H; Dong Q; Chen F; Huang Z; Zhang Y; Pan D; Xiong W
Mol Imaging Biol; 2015 Jun; 17(3):337-44. PubMed ID: 25323104
[TBL] [Abstract][Full Text] [Related]
42. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
43. High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
Denoyer D; Greguric I; Roselt P; Neels OC; Aide N; Taylor SR; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2010 Mar; 51(3):441-7. PubMed ID: 20150254
[TBL] [Abstract][Full Text] [Related]
44. Preclinical Evaluation of
Demirci E; Ahmed R; Ocak M; Latoche J; Radelet A; DeBlasio N; Mason NS; Anderson CJ; Mountz JM
Mol Imaging; 2017 Jan; 16():1536012116685941. PubMed ID: 28654376
[TBL] [Abstract][Full Text] [Related]
45. 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy.
Sun X; Yan Y; Liu S; Cao Q; Yang M; Neamati N; Shen B; Niu G; Chen X
J Nucl Med; 2011 Jan; 52(1):140-6. PubMed ID: 21149494
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of adenosine preconditioning with 99mTc-His10-annexin V in a porcine model of myocardium ischemia and reperfusion injury: preliminary study.
Ye F; Fang W; Wang F; Hua ZC; Wang Z; Yang X
Nucl Med Biol; 2011 May; 38(4):567-74. PubMed ID: 21531294
[TBL] [Abstract][Full Text] [Related]
47. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
[TBL] [Abstract][Full Text] [Related]
48. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive Whole-Body Imaging of Phosphatidylethanolamine as a Cell Death Marker Using
Delvaeye T; Wyffels L; Deleye S; Lemeire K; Gonçalves A; Decrock E; Staelens S; Leybaert L; Vandenabeele P; Krysko DV
J Nucl Med; 2018 Jul; 59(7):1140-1145. PubMed ID: 29419481
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and evaluation of a
Mikaeili A; Erfani M; Sabzevari O
Nucl Med Biol; 2017 Nov; 54():10-17. PubMed ID: 28810154
[TBL] [Abstract][Full Text] [Related]
51. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Wang F; Wang Z; Yao W; Xie H; Xu J; Tian L
J Nucl Med; 2007 Sep; 48(9):1442-8. PubMed ID: 17704242
[TBL] [Abstract][Full Text] [Related]
52. Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer.
Alberini JL; Boisgard R; Guillermet S; Siquier K; Jego B; Thézé B; Urien S; Rezaï K; Menet E; Maroy R; Dollé F; Kühnast B; Tavitian B
Mol Imaging Biol; 2016 Aug; 18(4):617-26. PubMed ID: 26630973
[TBL] [Abstract][Full Text] [Related]
53. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.
Ke S; Wen X; Wu QP; Wallace S; Charnsangavej C; Stachowiak AM; Stephens CL; Abbruzzese JL; Podoloff DA; Li C
J Nucl Med; 2004 Jan; 45(1):108-15. PubMed ID: 14734682
[TBL] [Abstract][Full Text] [Related]
54. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
55.
Erfani M; Shabani Z; Shamsaei M; Shirmardi SP; Shafiei M
J Labelled Comp Radiopharm; 2016 Nov; 59(13):582-588. PubMed ID: 27782316
[TBL] [Abstract][Full Text] [Related]
56. In vivo imaging of radiation-induced tissue apoptosis by (99m)Tc(I)-his (6)-annexin A5.
Lin KJ; Wu CC; Pan YH; Chen FH; Fu SY; Chiang CS; Hong JH; Lo JM
Ann Nucl Med; 2012 Apr; 26(3):272-80. PubMed ID: 22278351
[TBL] [Abstract][Full Text] [Related]
57. Predictive Value of [
Gu B; Liu S; Sun Y; Zhang J; Zhang Y; Xu X; Yuan H; Wang M; Zhang Y; Yang Z
Mol Imaging Biol; 2019 Jun; 21(3):538-548. PubMed ID: 30218389
[TBL] [Abstract][Full Text] [Related]
58. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
[TBL] [Abstract][Full Text] [Related]
59. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
[TBL] [Abstract][Full Text] [Related]
60. Preclinical assessment of early tumor response after irradiation by positron emission tomography with 2-amino-[3-¹¹C]isobutyric acid.
Tsuji AB; Sugyo A; Sudo H; Suzuki C; Wakizaka H; Zhang MR; Kato K; Saga T
Oncol Rep; 2015 May; 33(5):2361-7. PubMed ID: 25813536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
